Illumina, Inc. (ILMN) vs Revvity Inc. (RVTY)

Illumina, Inc. and Revvity Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $31.5B against $16.8B — 1.9× the size. Illumina, Inc. trades at the lower P/E: 35.6× against 71.9×. Illumina, Inc. grew revenue faster over the last twelve months: 5.83% against 4.56%. Illumina, Inc. has the higher net margin (19.7% vs 8.61%) and the higher return on invested capital (16.7% vs 2.50%). Across the 22 metrics below, Illumina, Inc. leads on 14 and Revvity Inc. on 8.

Valuation

Metric ILMN RVTY Diagnostics & Research median
P/E 35.62 71.89 34.52
P/S 6.98 5.73 4.24
P/B 10.07 2.33 3.42
Price to free cash flow 30.41 28.19 33.51
EV/EBITDA 26.35 25.08 23.44
EV/Sales 7.19 6.61 5.18
Earnings yield 2.81% 1.39% (1.50%)
Free cash flow yield 3.29% 3.55% 0.00%

Profitability

Metric ILMN RVTY Diagnostics & Research median
Gross margin 67.87% 55.91% 48.32%
Operating margin 21.18% 12.65% (5.68%)
Net margin 19.72% 8.61% (4.10%)
Free cash flow margin 23.29% 20.48% 0.00%
Return on equity 32.39% 0.00% 0.00%
Return on assets 13.78% 2.14% (6.05%)
Return on invested capital 16.70% 2.50% 0.00%

Growth

Metric ILMN RVTY Diagnostics & Research median
Revenue growth (TTM) 5.83% 4.56% 8.99%
EPS growth (last fiscal year) 170.87% (5.91%) 20.36%
Revenue growth, 5-year CAGR 6.04% 1.41% 7.30%
Net income growth, 5-year CAGR 5.32% (19.82%) 0.00%

Health

Metric ILMN RVTY Diagnostics & Research median
Debt to equity 0.57 0.36 0.01
Current ratio 2.63 2.65 2.27
Net debt to EBITDA (0.13) 3.00 0.68

Dividend

Metric ILMN RVTY Diagnostics & Research median
Dividend yield — 0.19% 0.67%
Payout ratio — 0.12 0.20

Size

Metric ILMN RVTY Diagnostics & Research median
Market cap 31.45b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack